NIH is reinforcing reproducibility expectations, shifting how reviewers assess credibility and forcing applicants to rethink how rigor is built into study design.
Archives
What “Foreign Risk” Really Means for SBIR/STTR Applicants, And Why Silence Is Now Part of the Process
SBIR/STTR proposals may be rejected over foreign risk without explanation, leaving companies unable to understand, mitigate, or correct underlying concerns.
How to understand the difference between NIH Highlighted Topics and Funding Opportunities
NIH clarifies the difference between Highlighted Topics and Funding Opportunities. Misunderstanding the distinction can undermine proposal success.
How to understand NIH emergency peer-review modifications and why they matter right now
NIH introduced emergency peer-review modifications that affect evaluation, timelines, and committee operations. Here is what applicants need to know.